<DOC>
	<DOCNO>NCT01387217</DOCNO>
	<brief_summary>This protocol describe first administration GSK2018682 human . The study evaluate safety , tolerability , pharmacokinetics pharmacodynamics single ascend dos GSK2018682 . The study also provide preliminary evidence potential therapeutic dose-range measure inhibitory effect GSK2018682 total lymphocyte count .</brief_summary>
	<brief_title>GSK2018682 FTIH Healthy Volunteers</brief_title>
	<detailed_description>This protocol describe first administration GSK2018682 human . The study evaluate safety , tolerability , pharmacokinetics pharmacodynamics single ascend dos GSK2018682 . The study also provide preliminary evidence potential therapeutic dose-range measure inhibitory effect GSK2018682 total lymphocyte count .</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . A subject clinical abnormality laboratory parameter significantly outside reference range population study may include Investigator GSK Medical Monitor agree find unlikely introduce additional risk factor interfere study procedure . Subjects lymphocyte count outside normal range always exclude enrollment BMI within range 19 28 kg/m2 ( inclusive ) . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug/alcohol screen . A positive test HIV antibody . History regular alcohol consumption Subjects history , examination suspicious , skin cancer ( ) include melanoma , basal cell squamous cell carcinoma . Systolic blood pressure le 95 mmHg great 140 mmHg , diastolic blood pressure less equal 50 mmHg great equal 95 mmHg . Symptomatic reduction blood pressure orthostatic challenge . Subjects rest heart rate le 45 beat per minute great 90 beat per minute Other criterion may apply defined clinical protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>GSK2018682</keyword>
	<keyword>First Time Human</keyword>
	<keyword>Healthy Volunteer</keyword>
</DOC>